$Wave Life Sciences (WVE.US)$ NEWS Wave Life Sciences Announ...
NEWS
Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing
Wave Life Sciences announces continued momentum in GSK collaboration with the selection of two programs for development, initiation of clinical trials for the INHBE program in obesity, and upcoming presentations at key conferences. GSK collaboration progresses with an aggregate initiation payment of $12 million for two oligonucleotide programs using Wave's next generation GalNAc-siRNA format. Wave expects up to $3.3 billion in potential milestone payments and tiered royalties on net sales from the collaboration.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment